Highlights and Quick Summary
- Trade and Non-Trade Receivables Growth for the quarter ending December 31, 2022 was 12.6 (a Infinity% increase compared to previous quarter)
- Year-over-year quarterly Trade and Non-Trade Receivables Growth decreased by -2620.0%
- Annual Trade and Non-Trade Receivables Growth for 2022 was 0.0 (a -100.0% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2022 was -0.88 (a -Infinity% decrease from previous year)
- Annual Trade and Non-Trade Receivables Growth for 2021 was 0.0 (a -100.0% decrease from previous year)
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Trade and Non-Trade Receivables Growth of Benitec Biopharma Limited
Most recent Trade and Non-Trade Receivables Growthof BNTC including historical data for past 10 years.Interactive Chart of Trade and Non-Trade Receivables Growth of Benitec Biopharma Limited
Benitec Biopharma Limited Trade and Non-Trade Receivables Growth for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 12.6 | 0.0 | -0.88 | -0.5 | 0.0 |
| 2021 | -0.76 | -0.83 | -0.58 | -0.99 | 0.0 |
| 2020 | -0.98 | -1.0 | -0.99 | 0.15 | 0.0 |
| 2019 | – | – | – | 44.35 | 0.0 |
| 2018 | – | – | – | – | 0.05 |
| 2017 | – | – | – | 199.23 | -0.02 |
| 2016 | – | 48.94 | 10.83 | -0.82 | -0.02 |
| 2015 | – | – | -0.8 | -0.98 | -0.08 |
| 2014 | – | – | -0.92 | 4.5 | 0.04 |
| 2013 | 4.0 | – | – | – | -0.03 |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology